Senate passes bill clarifying coverage for biomarker testing
Senate Bill 169, described as a cleanup to last year's biomarker law, requires coverage for biomarker tests when clinical utility is shown and limits conditioning coverage on unrelated laboratory credentialing; final passage recorded 35–0.
The full story
Senator Talbot described Senate Bill 169 as a technical cleanup to last year’s biomarker testing law and said the measure ‘‘just requires coverage for biomarker testing when clinical utility is demonstrated’’ and clarifies that coverage should not be conditioned on laboratory classifications unrelated to test performance.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or